Medindia

Pipra A (10 mg) (Aripiprazole) Drug Price and Information

Aripiprazole (Pipra A (10 mg)) is an atypical antipsychotic and antidepressant, prescribed for schizophrenia and depression. It regulates abnormal conditions like disturbed or unusual thinking, loss ...
Medscape

Intramuscular Aripiprazole May Be Effective Against Acute Agitation in Psychosis

Oct. 13, 2004 (Stockholm) — The atypical antipsychotic aripiprazole (Abilify) is as effective as haloperidol and significantly more effective than placebo at treating acute agitation in psychotic ...
EurekAlert!

US FDA approves ABILIFY for adolescent patients with schizophrenia

TOKYO, JAPAN and PRINCETON, NJ, Nov. 6, 2007 -- Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) approved ...
MedPage Today

Aripiprazole (Abilify) Potentially Useful for Treating Alcohol Dependence

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FARMINGTON, Conn ...
Medscape

Aripiprazole for Irritability Associated with Autistic Disorder in Children and Adolescents Aged 6–17 Years

Pediatr Health. 2010;4(4):375-381. In the retrospective study performed by Valicenti-McDermott and Demb, the mean BMI increased from 23.3 to 24. [17] The change was clinically significant for those ...
health.economictimes.indiatimes

Dr. Reddy's launches Aripiprazole tablets in US market

Dr. Reddy’s Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30. Hyderabad: Dr. Reddy’s Laboratories Ltd on Thursday announced that it has ...
National Institute for Health and Care Excellence

Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder

The manufacturer presented direct clinical-effectiveness evidence from 2 randomised controlled trials comparing aripiprazole with placebo and performed a meta-analysis of these trials. The ...
PharmiWeb

Abilify Maintena® 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of schizophrenia

Aripiprazole’s new long-acting injectable (LAI) formulation enables continuous exposure to medication for two months 1. Aripiprazole once-every-two-months LAI is a new formulation containing 960 mg ...
FiercePharma

ABILIFY® (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or

PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has approved ...
FiercePharma

FDA Approves Deltoid Injection Site for Abilify Maintena® (aripiprazole) for extended-release injectable suspension in the Treatment of Schizophrenia

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Otsuka America Pharmaceutical, Inc. (OAPI) and Lundbeck today announced that the U.S. Food and Drug Administration (FDA) has expanded the label of ...
Medindia

Arize (10 mg) (Aripiprazole) Drug Price and Information

Aripiprazole (Arize (10 mg)) is an atypical antipsychotic and antidepressant, prescribed for schizophrenia and depression. It regulates abnormal conditions like disturbed or unusual thinking, loss of ...